Related references
Note: Only part of the references are listed.Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins With Cyclosporine
Donald G. Lamprecht et al.
ANNALS OF PHARMACOTHERAPY (2017)
Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study
Samrat Yeramaneni et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
Modulation of the Gut Microbiota by Krill Oil in Mice Fed a High-Sugar High-Fat Diet
Chenyang Lu et al.
FRONTIERS IN MICROBIOLOGY (2017)
Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients
Hoda M. Eid et al.
FRONTIERS IN PHARMACOLOGY (2017)
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis
Bjorn W. Karlson et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways
Kai He et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Metabolic endotoxemia with obesity: Is it real and is it relevant?
Nabil E. Boutagy et al.
BIOCHIMIE (2016)
Safety of atorvastatin in Asian patients within clinical trials
Juliana C. N. Chan et al.
CARDIOVASCULAR THERAPEUTICS (2016)
Triglyceride-Lowering Effects of Two Probiotics, Lactobacillus plantarum KY1032 and Lactobacillus curvatus HY7601, in a Rat Model of High-Fat Diet-Induced Hypertriglyceridemia
Il-Dong Choi et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2016)
The role of the intestinal microbiota in type 1 diabetes mellitus
Mikael Knip et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Microbes offer engineering strategies to combat cancer
Susan E. Erdman
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Oat products modulate the gut microbiota and produce anti-obesity effects in obese rats
Ji-lin Dong et al.
JOURNAL OF FUNCTIONAL FOODS (2016)
Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
Baohong Wang et al.
SCIENTIFIC REPORTS (2016)
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
Jingyuan Fu et al.
CIRCULATION RESEARCH (2015)
Lipoproteins, Stroke and Statins
Livia Pisciotta et al.
CURRENT VASCULAR PHARMACOLOGY (2015)
Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia
Cheng Ding et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Potential role of the intestinal microbiota in programming health and disease
Olivier Goulet
NUTRITION REVIEWS (2015)
Induction of Peroxisomes by Butyrate-Producing Probiotics
Huachun Weng et al.
PLOS ONE (2015)
Gut microbiota and allergic disease: new findings
Christina E. West
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2014)
Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study
Panagiotis Anagnostis et al.
OPEN CARDIOVASCULAR MEDICINE JOURNAL (2014)
454 pyrosequencing analyses of bacterial and archaeal richness in 21 full-scale biogas digesters
Carina Sundberg et al.
FEMS MICROBIOLOGY ECOLOGY (2013)
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Magnus Simren et al.
GUT (2013)
Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
Hitoshi Endo et al.
PLOS ONE (2013)
Reduced dietary salt for the prevention of cardiovascular disease (Withdrawn
Alma J. Adler et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
PROGRESS IN THE KNOWLEDGE OF THE INTESTINAL HUMAN MICROBIOTA
Virginia Robles-Alonso et al.
NUTRICION HOSPITALARIA (2013)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet
J. Wang et al.
JOURNAL OF DAIRY SCIENCE (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Diversity, stability and resilience of the human gut microbiota
Catherine A. Lozupone et al.
NATURE (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
UCHIME improves sensitivity and speed of chimera detection
Robert C. Edgar et al.
BIOINFORMATICS (2011)
FLASH: fast length adjustment of short reads to improve genome assemblies
Tanja Magoc et al.
BIOINFORMATICS (2011)
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons
Brian J. Haas et al.
GENOME RESEARCH (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes
Ben P. Willing et al.
GASTROENTEROLOGY (2010)
QIIME allows analysis of high-throughput community sequencing data
J. Gregory Caporaso et al.
NATURE METHODS (2010)
Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal
Patrice D. Cani et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Patrick D. Schloss et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)
Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota
Patrice D. Cani et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Interaction between Phenolics and Gut Microbiota: Role in Human Health
Maria V. Selma et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Gastrointestinal microbiota in irritable bowel syndrome: Their role in its pathogenesis and treatment
Gareth C. Parkes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Comparing the squared multiple correlation coefficients of non-nested models: An examination of confidence intervals and hypothesis testing
Razia Azen et al.
BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY (2008)
Worlds within worlds: evolution of the vertebrate gut microbiota
Ruth E. Ley et al.
NATURE REVIEWS MICROBIOLOGY (2008)
A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model
Francois-Pierre J. Martin et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Fredrik Backhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ecological and evolutionary forces shaping microbial diversity in the human intestine
RE Ley et al.
CELL (2006)
The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis
JR Cole et al.
NUCLEIC ACIDS RESEARCH (2005)
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
VG Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2002)
Share Paper
